GEMMA Biotherapeutics is a therapeutics company focused on advancing gene therapy research and expanding access to therapies for rare diseases.

DermBiont is a clinical-stage biotechnology company that develops targeted topical therapeutics for dermatological indications, with a focus on treating seborrheic keratoses and melasma.